Thursday, July 3, 2008

Cost Studies in Rheumatology, 2001-2002


Cost Studies in Rheumatology, 2001-2002

from Current Opinion in Rheumatology

Management of Infected Total Joint Replacement

Fisman et al.[9] performed an excellent study examining the cost-effectiveness of two-stage exchange arthroplasty and open debridement with prosthesis retention in elderly patients with infected total hip arthroplasty. Lifetime direct medical costs as well as indirect costs from loss of productivity were assessed using a Markov model. Incremental ratios demonstrated that when compared with exchange arthroplasty, initial debridement and retention had lower cost-effectiveness ratios ($500-$21,800/QALY) in all cohorts regardless of gender.

This is a part of article Cost Studies in Rheumatology, 2001-2002 Taken from "Leflunomide Arava 20Mg" Information Blog

No comments: